New data from GenSight Biologics showed promising results for lenadogene nolparvovec (LUMVOQ), an intravitreal gene therapy for leber hereditary ...
https://www.google.com/url?rct=j&sa=t&url=https://www.hcplive.com/view/gene-therapy-gs010-safe-well-tolerated-lhon-patients&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNFys3vbUmMloTmd3ynXfIIslXSg5Q
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.